Status:
COMPLETED
Daxor - Blood Volume Analysis
Lead Sponsor:
Duke University
Collaborating Sponsors:
Daxor Corporation
Conditions:
Heart Failure
Congestive Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to better understand blood volume status and whether knowledge of it can change and improve heart failure care.
Detailed Description
The purpose of this study is to better understand measurements of various parameters of congestion, the most significant of which is blood volume analysis. Blood volume analysis (BVA) measures how muc...
Eligibility Criteria
Inclusion
- \- Admission for acute decompensated heart failure to the cardiology service at Duke Hospital, Durham, North Carolina
Exclusion
- Age \< 18 years
- Ongoing pregnancy
- Recent acute MI or hemodynamic instability: Acute MI (STEMI or Type I NSTEMI) within 7 days
- Post heart transplantation or ongoing mechanical circulatory support
- Progressive cardiogenic shock
- Patients with Ventricular Assist Devices
- End stage renal disease
Key Trial Info
Start Date :
July 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04111185
Start Date
July 16 2020
End Date
September 23 2021
Last Update
June 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University
Durham, North Carolina, United States, 27710